Skip to content

Zai Lab

US · ZLAB #2554 by market cap Listed 2017
21.03 -0.89 -4.06%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $37
    Market Newswire · 2026/2/27
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $53
    Market Newswire · 2026/2/23
  • Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/10/19
  • U.S. Stock Market Movements | Zai Lab (ZLAB.US) rises over 2% on positive Phase I data for investigational ADC Zolbetuximab
    Zhitong Finance · 2026/10/23
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/8/7
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $27
    Market Newswire · 2026/5/23
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $47
    Market Newswire · 2026/2/27
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating
    Market Newswire · 2026/4/21
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $44
    Market Newswire · 2026/5/8
  • Rating change
    J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)
    TipRanks · 2026/9/2
  • J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $36
    Market Newswire · 2026/9/2
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/3/10
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)
    TipRanks · 2026/3/26
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $32
    Market Newswire · 2026/3/26
  • Rating change
    BofA Securities Maintains Zai Lab(ZLAB.US) With Hold Rating, Cuts Target Price to $21.8
    Market Newswire · 2026/2/27
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/8/27
  • Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37
    Market Newswire · 2026/10/26
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $32
    Market Newswire · 2026/3/18
  • Rating change
    Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $53
    Market Newswire · 2026/2/20
  • Earnings Flash (ZLAB) Zai Lab Limited Reports Q3 Loss of $0.41 per ADS, Vs. FactSet Est of $-0.58
    MT Newswires · 2026/11/5
  • Rating change
    J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $39
    Market Newswire · 2026/2/5
  • U.S. Stocks Move | Zai Lab (ZLAB.US) Surges Over 12% as Q2 Product Revenue Rises 11% Sequentially
    Zhitong Finance · 2026/8/6
  • US Stock Movement | Shares Surge for Two Consecutive Days! Zai Lab (ZLAB.US) Rises Over 10%
    Zhitong Finance · 2026/8/7
  • Rating change
    Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37
    Market Newswire · 2026/8/7

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Zai Lab discussion 0 comments

Add a comment